MEDICINES CO. v. MYLAN, INC.

2015-1113, 2015-1151, 2015-1181.

853 F.3d 1296 (2017)

The MEDICINES COMPANY, Plaintiff-Cross-Appellant v. MYLAN, INC., Mylan Pharmaceuticals Inc., Bioniche Pharma USA, LLC, Defendants-Appellants.

United States Court of Appeals, Federal Circuit.

Decided: April 6, 2017.


Attorney(s) appearing for the Case

PORTER F. FLEMING , Haug Partners LLP, New York, NY, argued for plaintiff-cross-appellant. Also represented by EDGAR HAUG , ANGUS CHEN.

SHANNON BLOODWORTH , Perkins Coie, LLP, Washington, DC, argued for defendants-appellants. Also represented by DAN L. BAGATELL , Hanover, NH; DAVID LEE ANSTAETT , AUTUMN N. NERO , DAVID R. PEKAREK KROHN , Madison, WI.

Before Dyk, Wallach, and Hughes, Circuit Judges.


The Medicines Company ("Medicines") is the owner of U.S. Patent Nos. 7,582,727 ("the '727 patent") and 7,598,343 ("the '343 patent"). In response to an Abbreviated New Drug Application ("ANDA") submitted by Mylan, Inc. ("Mylan"), Medicines filed suit in the United States District Court for the Northern District of Illinois alleging...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases